Kovacs Shane William Charles 4
4 · Olema Pharmaceuticals, Inc. · Filed Nov 22, 2023
Insider Transaction Report
Form 4
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF.
Transactions
- Award
Common Stock
2023-11-20+36,750→ 443,729 total - Sale
Common Stock
2023-11-21$15.27/sh−700$10,689→ 434,132 total - Sale
Common Stock
2023-11-21$14.83/sh−8,897$131,943→ 434,832 total - Sale
Common Stock
2023-11-22$13.89/sh−9,145$127,024→ 424,987 total
Footnotes (6)
- [F1]On November 11, 2022, the Reporting Person was granted certain performance restricted stock units ("PRSUs") for 105,000 shares, which are subject to vesting upon certification by the Compensation Committee of the Company's achieving two different performance milestones. The Compensation Committee certified on November 20, 2023 that 35% of the award vested based upon the certification by the Compensation Committee as to certain performance criteria.
- [F2]Includes 9,034 shares acquired under the issuer's Employee Stock Purchase Plan on May 15, 2023 and 1,748 shares acquired under the issuer's Employee Stock Purchase Plan on November 15, 2023.
- [F3]The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of PRSUs. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- [F4]The weighted average sale price for the transaction reported was $14.83, and the range of prices was between $14.18 and $15.17. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F5]The weighted average sale price for the transaction reported was $15.27, and the range of prices was between $15.22 and $15.38. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F6]The weighted average sale price for the transaction reported was $13.89, and the range of prices was between $13.62 and $14.17. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.